InvestorsHub Logo
Followers 1
Posts 298
Boards Moderated 0
Alias Born 11/16/2017

Re: SAMNOTSAMUEL post# 30757

Sunday, 01/21/2018 8:23:13 PM

Sunday, January 21, 2018 8:23:13 PM

Post# of 50154
In 2016/17 a deal could not be reached IMO because HB had a death grip on Delcath with their toxic financing and holding their patents as leverage and would have made it difficult for any offers if any were made because they were right where they wanted to be and did not want anything to change. Shorting the stock and then selling convertible notes issued at a discount creating a guaranteed SP free-fall and was just to profitable of a position to let go of. At that point Delcath was on much more shaky ground as to where they stood on the FOCUS trial as well. That was most likely seen as way to big of a risk factor for any acquirer to feel that then was a good time to make a move.

Now we start 2018 with convertible debt paid off and patents free and positive interim safety analysis under our belt I feel we are in a much more desirable position for anyone to consider buying,merging or entering into a strategic alliance with Delcath. Obviously it is by no means a sure thing. But the environment is becoming much more conducive for a such a thing to take place.

P.S. As much as you like to try and discount the significance of Simon Pedder being added to the board IMO you are just wrong. I think that he will end up playing an important roll in the future. We will see.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News